| Nov 19 |
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
|
| Nov 19 |
Top 3 Health Care Stocks You'll Regret Missing In Q4
|
| Nov 11 |
Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual ...
|
| Nov 1 |
Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...
|
| Oct 31 |
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
|
| Oct 31 |
Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript
|
| Oct 31 |
Amarin Corporation plc (AMRN) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
Amarin Corporation plc 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 30 |
Amarin: Q3 Earnings Snapshot
|
| Oct 30 |
Amarin Non-GAAP EPS of -$0.05 beats by $0.01, revenue of $42.3M misses by $2.21M
|
